Organization
Centro de Cancer de Brasilia
6 abstracts
Abstract
Pathologic concordance rate and outcomes by histologic subtype in advanced papillary renal cell (pRCC) carcinoma: An analysis from the SWOG S1500 (PAPMET) trial.Org: City of Hope Comprehensive Cancer Center, SWOG Statistics and Data Management Center, Seattle, WA, University of Washington and Fred Hutchinson Cancer Research Centre, Yale School of Medicine, Yale University,
Abstract
Health-related quality of life (HR-QOL) measures in renal cell carcinoma (RCC): Patient-reported relevance of items of the FKSI-19, EORTC QLQ-C30, and EQ-5D.Org: Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Rio De Janeiro, Brazil, City of Hope Comprehensive Cancer Center, Centro de Cancer de Brasilia, Instituto Unity de Ensino e Pesquisa, Grupo Oncoclinicas,
Abstract
Adjuvant everolimus in patients (Pts) with localized non-clear cell renal cell carcinoma (RCC): Subgroup analysis from the Everest trial (SWOG S0931).Org: University of California Davis Comprehensive Cancer Center, SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Oregon Health & Science University, Knight Cancer Institute,
Abstract
Nutritional program among patients with prostate cancer receiving androgen deprivation therapy (ADT).Org: Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Rio De Janeiro, Brazil, Brasília, Brazil, Brazil, Brasilia, Brazil, Centro de Cancer de Brasilia,
Abstract
Patterns of recurrence post prostatectomy in the PSMA era: What lessons can we take to daily practice from a high-volume nuclear medicine center?Org: Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Rio De Janeiro, Brazil, Imagens Medicas de Brasilia, IMEB, Centro de Cancer de Brasilia, Grupo Oncoclinicas,
Abstract
A supervised remote exercising program for patients receiving immunotherapy alone or in combination with chemotherapy in Brazil: ExIO.Org: Centro de Cancer de Brasilia, Instituto Unity de Ensino e Pesquisa, Grupo Oncoclinicas, Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Rio De Janeiro, Brazil, Hospital Universitario de Brasilia,